Opiant Pharmaceuticals Investor Relations Material
Latest events
Q2 2022
Opiant Pharmaceuticals
Investor Presentation
16 Feb, 2023
Q4 2022
16 Feb, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Opiant Pharmaceuticals Inc
Access all reports
Opiant Pharmaceuticals Inc. specialized in the development of treatments for addiction and drug overdose. The company focused on advancing pharmaceutical therapies based on proprietary formulations and delivery methods. Its work involved both research and regulatory development activities. The company was headquartered in Santa Monica, California, and its shares were listed on the NASDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
OPNT
Country
🇺🇸 United States